Skip to content

Clinical trials

Prostatic Hyperplasia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Country / region: United States Clear all

185 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20023
20035
20042
200510
20066
20077
20089
200910
20106
20117
20122
201310
20148
20158
20165
20176
20187
20193
20208
202112
202210
20234
202411
20258
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed97
Recruiting25
Terminated20
Active, not recruiting15
Unknown status12
Withdrawn9
Not yet recruiting5
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company9
Northwestern University9
GlaxoSmithKline8
NeoTract, Inc.5
Nymox Corporation5
University of California, San Francisco5
University of Kansas Medical Center5
Boston Scientific Corporation4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)4
Watson Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia185
Lower Urinary Tract Symptoms44
Prostatic Neoplasms21
Kidney Calculi6
Urinary Bladder, Overactive6
Nocturia5
Urinary Incontinence5
Hyperplasia4
Prostatic Diseases4
Erectile Dysfunction3

Trials

Showing 1 to 25 of 185. Each trial links to its page on Pharma Observatory.

85 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.